CI_ChemClass CI_MoA CI_with has_DoseForm has_Ingredient has_MoA has_PE may_treat drug associated with AE Monoamine Oxidase Inhibitors [MoA] Adrenergic alpha-Agonists [MoA] Hypersensitivity [Disease/Finding] Hypotension [Disease/Finding] Shock [Disease/Finding] Halothane [Chemical/Ingredient] Cyclopropanes [Chemical/Ingredient] Decreased GI Smooth Muscle Tone [PE] Decreased Striated Muscle Contraction [PE] Positive Chronotropy [PE] Positive Inotropy [PE] Vasoconstriction [PE] [AU100] SYMPATHOMIMETICS (ADRENERGICS) Injectable Solution [Dose Form] METARAMINOL BITARTRATE METARAMINOL BITARTRATE 10MG/ML INJ [VA Product] METARAMINOL BITARTRATE INJ,SOLN VA Product N0000151102 10 重酒石酸间羟胺注射液 4002977 C0978481 311568 0 C45752 METARAMINOL BITARTRATE 10MG/ML INJ <VANDF_Record>50.68^2395^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>2395</VA_IEN><VA_Status>Inactive/Master</VA_Status> MG/ML Metaraminol 10 MG/ML Injectable Solution <Product_Component>METARAMINOL BITARTRATE</Product_Component><Strength>10</Strength><Unit>MG/ML</Unit><VA.IEN>553</VA.IEN> Metaraminol Bitartrate [Chemical/Ingredient] cardiac disorder AE acute pulmonary edema AE convulsion AE hypotension AE arrhythmia AE severe hypertension AE severe arrhythmia AE METARAMINOL BITARTRATE 10MG/ML INJ [VA Product] METARAMINOL BITARTRATE INJ,SOLN VA Product N0000151102 311568 0 C45752 10 METARAMINOL BITARTRATE 10MG/ML INJ 重酒石酸间羟胺注射液 MG/ML Metaraminol 10 MG/ML Injectable Solution <VANDF_Record>50.68^2395^Inactive/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>2395</VA_IEN><VA_Status>Inactive/Master</VA_Status> <Product_Component>METARAMINOL BITARTRATE</Product_Component><Strength>10</Strength><Unit>MG/ML</Unit><VA.IEN>553</VA.IEN> 4002977 C0978481